Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining and Treating a New Pediatric Asthma Endotype: Depression-related Asthma Mediated by the Cholinergic Pathway

NCT04617015 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT04617015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining and Treating a New Pediatric Asthma Endotype: Depression-related Asthma Mediated by the Cholinergic Pathway
Lead sponsor
State University of New York at Buffalo
Phase
Phase 1
Overall status
Completed
Start date
September 9, 2016
Completion date
March 11, 2019
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, childhood asthma, depression